123 related articles for article (PubMed ID: 35091184)
1. Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial.
Vakaet V; Van Hulle H; Van de Vijver K; Hilderson I; Naert E; De Neve W; Vandorpe J; Hendrix A; Göker M; Depypere H; Vergauwen G; Van den Broecke R; De Visschere P; Braems G; Vandecasteele K; Denys H; Veldeman L
Breast; 2022 Apr; 62():10-15. PubMed ID: 35091184
[TBL] [Abstract][Full Text] [Related]
2. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
[TBL] [Abstract][Full Text] [Related]
3. Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients.
Van Hulle H; Vakaet V; Post G; Van Greveling A; Monten C; Hendrix A; Van de Vijver K; Van Dorpe J; De Visschere P; Braems G; Vandecasteele K; Denys H; De Neve W; Veldeman L
Pilot Feasibility Stud; 2020; 6():154. PubMed ID: 33062295
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
[No Abstract] [Full Text] [Related]
5. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Haussmann J; Budach W; Nestle-Krämling C; Wollandt S; Tamaskovics B; Corradini S; Bölke E; Krug D; Fehm T; Ruckhäberle E; Audretsch W; Jazmati D; Matuschek C
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011025
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
8. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
[TBL] [Abstract][Full Text] [Related]
10. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G
Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399
[TBL] [Abstract][Full Text] [Related]
11. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
[TBL] [Abstract][Full Text] [Related]
12. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
13. Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer.
Chie EK; Kim K; Noh DY; Choe KJ; Kim TY; Im SA; Bang YJ; Ha SW
Tumori; 2007; 93(6):591-6. PubMed ID: 18338495
[TBL] [Abstract][Full Text] [Related]
14. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.
Polgár C; Fodor J; Major T; Takácsi-Nagy Z; Kásler M; Hammer J; Van Limbergen E; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):597-606. PubMed ID: 12426670
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
18. Impact of delayed radiotherapy on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant radiotherapy without chemotherapy.
Kim K; Chie EK; Han W; Noh DY; Ha SW
Tumori; 2011; 97(3):341-4. PubMed ID: 21789013
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer.
Chidley P; Foroudi F; Tacey M; Khor R; Yeh J; Bevington E; Hyett A; Loh SW; Chew G; McCracken J; Neoh D; Yeo B; Baker C; Jassal S; Law M; Zantuck N; Cokelek M; Guerrieri M; Brown B; Stoney D; Ng M; Chao M
J Med Imaging Radiat Oncol; 2021 Jun; 65(3):345-353. PubMed ID: 33821576
[TBL] [Abstract][Full Text] [Related]
20. Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors.
Bondiau PY; Bahadoran P; Lallement M; Birtwisle-Peyrottes I; Chapellier C; Chamorey E; Courdi A; Quielle-Roussel C; Thariat J; Ferrero JM
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1041-7. PubMed ID: 19386428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
